Patent details
LUC00110
Product Name:
1-(2,2-difluoro-2H-1,3-benzodioxol-5-yl)-N-{1-[(2R)-2,3- dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl}cyclopropane-1-carboxamide
Basic Information
- Publication number:
- LUC00110
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP088763644
- Legal Status:
- Inactive
- Application number:
- LUC00110
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/18/1306
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 06/11/2018
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 21/03/2019
- First Marketing Authorization date:
- 06/11/2018
- Grant date:
- 10/07/2020
- Activation date:
- Publication date:
- 25/03/2019
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 06/11/2033
- SPC Extension Expiration:
- 06/11/2033
- Rejection date:
- Withdrawal date:
Owner
- From:
- 21/03/2019
-
-
- Name:
- Vertex Pharmaceuticals Incorporated
- Address:
- 50 Northern Avenue, Boston, MA 02210, United States (US)
Agent
- Name:
- Dennemeyer & Associates S.A.
- From:
- 21/03/2019
- Address:
- PO Box 1502, L-1015, LUXEMBOURG, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2019/05
- Publication date:
- 11/04/2019
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2020/09
- Publication date:
- 04/08/2020
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Annual Fees
- Annual Fee Due Date:
- 30/11/2028
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-